These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24262877)

  • 1. Pelvic exenteration: impact of age on surgical and oncologic outcomes.
    Huang M; Iglesias DA; Westin SN; Fellman B; Urbauer D; Schmeler KM; Frumovitz M; Ramirez PT; Soliman PT
    Gynecol Oncol; 2014 Jan; 132(1):114-8. PubMed ID: 24262877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of body mass index on surgical outcomes and survival following pelvic exenteration.
    Iglesias DA; Westin SN; Rallapalli V; Huang M; Fellman B; Urbauer D; Frumovitz M; Ramirez PT; Soliman PT
    Gynecol Oncol; 2012 May; 125(2):336-42. PubMed ID: 22261299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
    Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
    Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.
    Benn T; Brooks RA; Zhang Q; Powell MA; Thaker PH; Mutch DG; Zighelboim I
    Gynecol Oncol; 2011 Jul; 122(1):14-8. PubMed ID: 21444105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
    Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
    J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
    Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
    Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overall survival after pelvic exenteration for gynecologic malignancy.
    Westin SN; Rallapalli V; Fellman B; Urbauer DL; Pal N; Frumovitz MM; Ramondetta LM; Bodurka DC; Ramirez PT; Soliman PT
    Gynecol Oncol; 2014 Sep; 134(3):546-51. PubMed ID: 25014540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
    Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
    Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
    Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
    Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
    de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
    Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
    Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
    Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
    Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
    Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tumor size on outcomes following pelvic exenteration.
    Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
    Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
    Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
    J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laparoscopy-assisted vaginal pelvic exenteration].
    Ferron G; Querleu D; Martel P; Chopin N; Soulié M
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
    Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
    Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer.
    Roos EJ; Van Eijkeren MA; Boon TA; Heintz AP
    Int J Gynecol Cancer; 2005; 15(4):624-9. PubMed ID: 16014116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.